Kinase Inhibitors for Anticancer Therapies

Dear Colleagues,

Targeting kinase pathways has emerged as a promising strategy in the fight against debilitating diseases such as cancer that involve aberrant expression of the kinases and infectious diseases caused by pathogenic microbes such as bacteria, viruses, parasites, or fungi. Targeting protein kinases for cancer treatment has emerged as a successful clinical strategy leading to a reduction in the mortality rate for several cancers. The discovery of the roles of additional protein kinase targets and the development of resistance to existing therapeutics has invigorated research for the development of new potential drug candidates as protein kinase inhibitors to combat cancer.

This Special Issue entitled “Kinase Inhibitors for Anticancer Therapies” will showcase the recent trends in the field of drug discovery of kinase inhibitors, especially for anticancer therapy. In addition, review articles, research articles, and short communications will highlight the efforts of medicinal chemists to propose new molecules endowed with kinase inhibition properties and the strategies to enhance the activity profile of the existing pipeline.

Dr. Jayalakshmi Sridhar
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.